S
Savara D
D
SVRA
2.27500
USD
-0.07
(-2.99%)
مغلق
حجم التداول
52,565
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
393,203,998
الأخبار المقالات
العنوان: Savara
القطاع: Healthcare
الصناعة: Biotechnology
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.